Johnson & Johnson
JNJ
NYSE
$163.36
-$1.17-0.71%
Volume8,985,190
09/30/2022 4:00PM Eastern
Quotes delayed
| 07/03/2022 | 04/03/2022 | 01/02/2022 | 10/03/2021 | 07/04/2021 | |
|---|---|---|---|---|---|
| Revenue | 24.02B | 23.43B | 24.80B | 23.34B | 23.31B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.02B | 23.43B | 24.80B | 23.34B | 23.31B |
| Cost of Revenue | 7.90B | 7.58B | 7.92B | 7.23B | 7.57B |
| Gross Profit | 16.12B | 15.84B | 16.88B | 16.11B | 15.75B |
| SG&A Expenses | 5.94B | 5.64B | 7.01B | 5.85B | 5.94B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.54B | 16.68B | 19.65B | 16.50B | 16.90B |
| Operating Income | 6.48B | 6.74B | 5.16B | 6.84B | 6.41B |
| Income Before Tax | 5.84B | 5.86B | 4.84B | 3.85B | 6.66B |
| Income Tax Expenses | 1.03B | 713.00M | 100.00M | 182.00M | 384.00M |
| Earnings from Continuing Operations | 4.81B | 5.15B | 4.74B | 3.67B | 6.28B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.81B | 5.15B | 4.74B | 3.67B | 6.28B |
| EBIT | 6.48B | 6.74B | 5.16B | 6.84B | 6.41B |
| EBITDA | 8.22B | 8.51B | 7.00B | 8.65B | 8.25B |
| EPS Basic | 1.83 | 1.96 | 1.80 | 1.39 | 2.38 |
| Normalized Basic EPS | 1.60 | 1.64 | 1.06 | 1.63 | 1.56 |
| EPS Diluted | 1.80 | 1.93 | 1.77 | 1.37 | 2.35 |
| Normalized Diluted EPS | 1.58 | 1.62 | 1.05 | 1.61 | 1.54 |
| Average Basic Shares Outstanding | 2.63B | 2.63B | 2.63B | 2.63B | 2.63B |
| Average Diluted Shares Outstanding | 2.67B | 2.67B | 2.67B | 2.67B | 2.67B |
| Dividend Per Share | 1.13 | 1.06 | 1.06 | 1.06 | 1.06 |
| Payout Ratio | 61.72% | 54.13% | 58.93% | 76.11% | 44.46% |
